PRECISIS GmbH
PRECISIS creates brain implants that reduce epilepsy seizures with minimally invasive electrodes. It uses miniaturized bioelectronic pacemakers and thin electrode pads under the skin, guided by AI-based models to activate or inhibit specific brain cells. The core tech combines bioelectronic therapy, neuromodulation, and brain stimulation, with EASEE as a focal-epilepsy treatment that has CE marking since 2022. The company targets clinicians and medical facilities, integrating with neurosurgical workflows to deliver treatment. The market focus is on neurology and epilepsy across clinical settings, aiming to expand access to a compact, implant-based therapy for neurological disorders.
PRECISIS GmbH
PRECISIS creates brain implants that reduce epilepsy seizures with minimally invasive electrodes. It uses miniaturized bioelectronic pacemakers and thin electrode pads under the skin, guided by AI-based models to activate or inhibit specific brain cells. The core tech combines bioelectronic therapy, neuromodulation, and brain stimulation, with EASEE as a focal-epilepsy treatment that has CE marking since 2022. The company targets clinicians and medical facilities, integrating with neurosurgical workflows to deliver treatment. The market focus is on neurology and epilepsy across clinical settings, aiming to expand access to a compact, implant-based therapy for neurological disorders.